UK markets closed

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
107.85-0.47 (-0.43%)
As of 12:40PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,834,204
3,834,204
3,659,374
3,094,238
2,363,567
Cost of revenue
435,577
435,577
540,517
440,760
148,917
Gross profit
3,398,627
3,398,627
3,118,857
2,653,478
2,214,650
Operating expenses
Research development
849,658
849,658
590,453
505,748
335,375
Selling general and administrative
1,343,105
1,343,105
1,416,967
1,451,683
854,233
Total operating expenses
2,801,047
2,801,047
2,606,589
2,483,200
1,449,188
Operating income or loss
597,580
597,580
512,268
170,278
765,462
Interest expense
289,438
289,438
288,242
278,766
99,707
Total other income/expenses net
-10,213
-10,213
-596,810
-4,350
-390,660
Income before tax
297,929
297,929
-372,784
-112,838
275,095
Income tax expense
-119,912
-119,912
-158,645
216,116
33,517
Income from continuing operations
414,832
414,832
-224,060
-329,668
238,616
Net income
414,832
414,832
-224,060
-329,668
238,616
Net income available to common shareholders
414,832
414,832
-224,060
-329,668
238,616
Basic EPS
1.20
6.55
-3.58
-5.52
4.28
Diluted EPS
0.83
6.10
-3.58
-5.52
4.22
Basic average shares
63,414
63,291
62,539
59,694
55,712
Diluted average shares
69,648
72,066
62,539
59,694
56,517